Hyperinsulinism due to HNF1A deficiency: A Patient Guide

Hyperinsulinism due to HNF1A deficiency is a rare genetic condition that can change how the pancreas regulates blood sugar throughout a person’s life. In infancy, this condition causes the pancreas to be overactive, releasing excessive amounts of insulin even when blood sugar levels are low ^[1]. This leads to hypoglycemia (low blood sugar), which requires prompt medical attention to ensure the brain has a steady supply of energy for growth and development ^[2]. Because this is a genetic condition, identifying a pathogenic HNF1A gene variant is a vital step in understanding why these low blood sugar events are happening and how they might behave over time ^[3]. Note that a Variant of Uncertain Significance (VUS) is not a diagnosis.

A rare aspect of this condition is a potential biphasic or “two-phase” nature, though evidence is based on selected families and small reports. While the first phase is defined by too much insulin in infancy, the same genetic change can eventually lead the pancreas to produce too little insulin later in life ^[4]. This possible second phase can result in a form of diabetes known as HNF1A-MODY (Maturity-Onset Diabetes of the Young, type 3) ^[5]. This means that while your current focus is on preventing “lows,” your child’s healthcare journey will eventually involve monitoring for “highs,” requiring a lifelong partnership with specialized endocrinologists to navigate these shifting needs ^[6].

Treatment during the infant stage often centers on a medication called diazoxide, which helps the pancreas “turn down” its insulin production. Families and doctors have observed in case reports that children with HNF1A-related hyperinsulinism may be unusually sensitive to this medication ^[7]. Because a standard dose might accidentally cause blood sugar to climb too high, care teams typically use very low starting doses and increase them slowly under supervision ^[8]. This tailored approach allows for precise control, helping to stabilize your child’s levels while minimizing side effects as they grow ^[7].

Beyond managing blood sugar, a diagnosis of HNF1A deficiency provides important information for the entire family. Because this condition is inherited, first-degree relatives—such as parents and siblings—may also carry the gene and benefit from cascade genetic testing to identify their own health risks ^[9]. Long-term care also includes specialist-directed surveillance for rare associated risks, such as liver adenomas, following clinical guidelines ^[10]. While the diagnosis brings a complex set of requirements, it also provides the clarity needed to monitor your child effectively and protect their health at every stage of life ^[5].